Detalles de la búsqueda
1.
Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database.
Ann Rheum Dis
; 81(3): 335-343, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34706874
2.
Resource Use and Cost of Alzheimer's Disease in France: 18-Month Results from the GERAS Observational Study.
Value Health
; 21(3): 295-303, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29566836
3.
Effectiveness of Florbetapir PET Imaging in Changing Patient Management.
Dement Geriatr Cogn Disord
; 44(3-4): 129-143, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28787712
4.
Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe.
BMC Psychiatry
; 15: 242, 2015 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26462666
5.
Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients.
BMC Musculoskelet Disord
; 15: 450, 2014 Dec 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25532971
6.
Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
Adv Ther
; 40(4): 1867-1883, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802049
7.
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases.
Rheumatol Ther
; 10(1): 201-223, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371760
8.
Open-label treatment with olanzapine for patients with borderline personality disorder.
J Clin Psychopharmacol
; 32(3): 398-402, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22544004
9.
Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis.
BMC Psychiatry
; 12: 130, 2012 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-22935168
10.
A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Adv Ther
; 39(11): 4910-4960, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063279
11.
Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials.
Rheumatol Ther
; 8(3): 1435-1441, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34184191
12.
Risk of Venous Thromboembolism Among Patients with Atopic Dermatitis: A Cohort Study in a US Administrative Claims Database.
Dermatol Ther (Heidelb)
; 11(3): 1041-1052, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33929715
13.
Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach.
Psychiatry Res
; 170(2-3): 161-7, 2009 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19897252
14.
Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy.
BMC Psychiatry
; 9: 44, 2009 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-19602273
15.
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
BMJ Open
; 9(6): e029663, 2019 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31239309
16.
Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.
Br J Psychiatry
; 193(6): 485-92, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19043153
17.
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
Adv Ther
; 40(9): 4114-4115, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347406
18.
Burden of illness and health care resource utilization in adult psychiatric outpatients with attention-deficit/hyperactivity disorder in Europe.
Curr Med Res Opin
; 32(9): 1547-56, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27171913
19.
Amantadine for weight gain associated with olanzapine treatment.
Eur Neuropsychopharmacol
; 15(1): 13-21, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15572269
20.
Safety and tolerability of atomoxetine in treatment of attention deficit hyperactivity disorder in adult patients: an integrated analysis of 15 clinical trials.
J Psychopharmacol
; 29(1): 3-14, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424623